IKT -

QQQ ()

DIA ()

SPY ()

TLT ()

GLD ()

Previous Close

$ na

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

-- - --

Volume

Average Volume

Market Cap

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

-- (--)

Last Ex-Dividend

1y Target Est

TBD --

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

12 Health Care Stocks Moving In Monday's P...
08/18/2025 12:08:41

Inhibikase Therapeutics To Initiate Phase ...
08/14/2025 21:06:54

-SEC Filing

Inhibikase Therapeutics Q2 EPS $(0.11) Mis...
08/14/2025 20:55:51

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate...

12 Health Care Stocks Moving In Monday's P...
06/30/2025 12:08:07

12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

Inhibikase Therapeutics Files For Mixed Sh...
06/20/2025 21:17:13

https://www.sec.gov/Archives/edgar/data/1750149/000119312525143738/d77556ds3.htm

Inhibikase Therapeutics Q1 EPS $(0.15) Mis...
05/14/2025 20:22:18

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate...

Inhibikase Therapeutics Appoints David McI...
04/14/2025 12:01:20

HC Wainwright & Co. Reiterates Neutral on ...
03/28/2025 17:26:08

HC Wainwright & Co. analyst Edward White reiterates Inhibikase Therapeutics (NASDAQ:IKT) from Neutral to Neutral.

Inhibikase Therapeutics FY 2024 GAAP EPS $...
03/27/2025 20:03:43

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate...

Inhibikase Appoints Mark Iwicki As CEO
02/18/2025 13:16:00

this-ppg-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday

This PPG Industries Analyst Is No Longer B...
02/12/2025 14:29:22

HC Wainwright & Co. Downgrades Inhibikase ...
02/12/2025 12:32:50

HC Wainwright & Co. analyst Edward White downgrades Inhibikase Therapeutics (NASDAQ:IKT) from Buy to Neutral.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/30/2025 21:06:56

Inhibikase Therapeutics Q3 2024 GAAP EPS $...
11/14/2024 13:57:53

Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
11/08/2024 16:32:01

this-cytokinetics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

This Cytokinetics Analyst Begins Coverage ...
11/08/2024 13:42:39

Jefferies Initiates Coverage On Inhibikase...
11/08/2024 12:16:52

Jefferies analyst Dennis Ding initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Pri...

why-tesla-shares-are-trading-higher-by-around-11-here-are-20-stocks-moving-premarket

Why Tesla Shares Are Trading Higher By Aro...
10/24/2024 10:21:11

IKT

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Search Symbol

Create a Free Account Sign in to your Account Reset Password

IKT

Create a Free Account Sign in to your Account Reset Password

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Add/Delete Symbol to your Portfolio